Vaccine News and Research

Latest Vaccine News and Research

Fina Biosolutions receives patent for expression and purification of the conjugate vaccine protein

Fina Biosolutions announces that the United States Patent and Trademark Office has issued a patent for expression and purification of the conjugate vaccine protein CRM197 in E. coli.

27 Sep 2018

New approach to vaccine development and improved surveillance could help target deadly diseases

Scientists hope that a new approach to vaccine development, combined with improved surveillance of potential future threats of outbreak, could help to massively reduce the impact of deadly diseases such as Ebola, Marburg and Lassa fever.

26 Sep 2018

Yellow fever virus can be transmitted via tiger mosquitoes, shows research

Since December 2016, Brazil has been grappling with its worst yellow fever outbreak for several decades. To date, there have been 2,043 human cases including 676 fatalities, mainly occurring in ten Brazilian states including Rio de Janeiro and São Paulo.

26 Sep 2018

Researchers develop promising allergy vaccine for hay fever

Using sugar molecules researchers from the University of Copenhagen have developed a new vaccine for hay fever that may reduce treatment times and increase the effect of treatments.

26 Sep 2018

Researchers aim to develop vaccine for 'traveler's diarrhea'

Every year, millions of people have vacations and business trips ruined when they succumb to "traveler's diarrhea" during their journeys. A major cause of traveler's diarrhea is bacteria called Enterotoxigenic E. coli, or ETEC.

26 Sep 2018

New TB vaccine effective in half of the population in phase II trials

GlaxoSmithKline has come up with an experimental vaccine against tuberculosis (TB) that has shown effective prevention of the infection in half of the population it has been administered to. This could be a breakthrough in preventing the killer disease say researchers since most of the recent vaccines developed against the disease have failed to show efficacy.

26 Sep 2018

UC Davis researchers take critical step in developing more effective Salmonella vaccine

UC Davis researchers announce in the Proceedings of the National Academy of Sciences this week a breakthrough in understanding which cells afford optimal protection against Salmonella infection--a critical step in developing a more effective and safe vaccine against a bacterium that annually kills an estimated one million people worldwide.

25 Sep 2018

Immunologist to study how Chikungunya causes devastating effects in older adults

Emerging viruses such as Ebola, SARS and swine flu are familiar sounding, yet seemingly distant diseases to many Americans. But that's not the case with Chikungunya, a mosquito-borne virus that recently struck close to home and has proven deadly for the elderly.

25 Sep 2018

Greater awareness of science can help public overcome fear of vaccines

The increasing distrust in vaccinations has triggered an extensive scientific and public debate over whether or not it is useful, safe and ethical to vaccinate children today.

24 Sep 2018

New therapeutic vaccine helps immune cells fight HPV-related head and neck cancer

A therapeutic vaccine can boost antibodies and T cells, helping them infiltrate tumors and fight off human papillomavirus-related head and neck cancer.

24 Sep 2018

Researchers demonstrate pre-clinical success for universal flu vaccine in new paper

Researchers from the University of Oxford's Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine in a new paper published in Nature Communications.

21 Sep 2018

Research finds drop in number of measles cases in the EU/EEA since March 2018

During the month of July, a total of 758 cases of measles were reported across seventeen countries in the EU/EEA, which is a decrease from the 1054 cases reported during the month of June.

21 Sep 2018

Study: Annual wellness visits improve delivery of preventive services in elderly population

new Harvey L. Neiman Health Policy Institute study assesses the effect of receiving an Annual Wellness Visit between 2011 and 2013 on the annual rate of eight preventive services recommended for the Medicare population following the AWV.

21 Sep 2018

Innovative approach for developing vaccine against most prevalent human malaria parasite

A novel study indicates promising avenues in an innovative approach for developing a vaccine against Plasmodium vivax, the most prevalent human malaria parasite outside sub-Saharan Africa.

20 Sep 2018

Pfizer’s 20vPnC vaccine receives Breakthrough Therapy designation from FDA

Pfizer Inc. announced today that its 20-Valent Pneumococcal Conjugate Vaccine candidate, PF-06482077, received Breakthrough Therapy designation from the US Food and Drug Administration for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes in the vaccine in adults aged 18 years and older. Pfizer expects to start Phase 3 trials in a few months.

20 Sep 2018

LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccines

Applied DNA Sciences Inc. announced today that LineaRx, Inc., its wholly-owned subsidiary focused on next-generation biotherapeutics, has signed a Joint Development Agreement with Takis S.R.L. and Evvivax S.R.L., biotechnology companies focused on the discovery and development of DNA based anti-cancer vaccines for the human and animal markets, respectively.

20 Sep 2018

Emergex signs MoU with Brazil’s Fiocruz for development of viral vaccines

Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to synthetic vaccine development in the field of infectious diseases, today announces that it has signed a Memorandum of Understanding with Brazil-based Oswaldo Cruz Foundation 'Fiocruz' for the development of viral vaccines.

20 Sep 2018

Vax-Hub to influenze radical change in development and manufacturing of vaccines

Vax-Hub, a new Future Vaccine Manufacturing Research Hub, will bring together academia, industry and policy makers to affect radical change in the development and manufacturing of vaccines and improve responses to outbreaks of deadly pandemics such as Swine Flu and Ebola.

20 Sep 2018

Zika virus could become a weapon against brain cancer

Zika virus infection is a dreaded one that can lead to severe brain damage in the unborn babies of mothers who get it.

20 Sep 2018

Analysis does not find any safety concerns of bivalent HPV vaccine

Infection with human papillomavirus can cause certain cancers in women and men, but HPV vaccines are highly effective in preventing infection with oncogenic HPV types.

19 Sep 2018

Vaccine News and Research

Latest Vaccine News and Research

Fina Biosolutions receives patent for expression and purification of the conjugate vaccine protein

New approach to vaccine development and improved surveillance could help target deadly diseases

Yellow fever virus can be transmitted via tiger mosquitoes, shows research

Researchers develop promising allergy vaccine for hay fever

Researchers aim to develop vaccine for 'traveler's diarrhea'

New TB vaccine effective in half of the population in phase II trials

UC Davis researchers take critical step in developing more effective Salmonella vaccine

Immunologist to study how Chikungunya causes devastating effects in older adults

Greater awareness of science can help public overcome fear of vaccines

New therapeutic vaccine helps immune cells fight HPV-related head and neck cancer

Researchers demonstrate pre-clinical success for universal flu vaccine in new paper

Research finds drop in number of measles cases in the EU/EEA since March 2018

Study: Annual wellness visits improve delivery of preventive services in elderly population

Innovative approach for developing vaccine against most prevalent human malaria parasite

Pfizer’s 20vPnC vaccine receives Breakthrough Therapy designation from FDA

LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccines

Emergex signs MoU with Brazil’s Fiocruz for development of viral vaccines

Vax-Hub to influenze radical change in development and manufacturing of vaccines

Zika virus could become a weapon against brain cancer

Analysis does not find any safety concerns of bivalent HPV vaccine

eBook: Advancing infectious disease vaccine development eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Vaccine News and Research

Latest Vaccine News and Research

eBook: Advancing infectious disease vaccine development eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Newsletters you may be interested in